FOUSE JACQUALYN A 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed Jun 24, 2024
Insider Transaction Report
Form 4
FOUSE JACQUALYN A
Director
Transactions
- Award
Restricted stock units
2024-06-20+2,120→ 2,120 total→ Common stock (2,120 underlying) - Award
Stock options (right to buy)
2024-06-20+11,774→ 11,774 totalExercise: $42.45Exp: 2034-06-20→ Common stock (11,774 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on June 20, 2024. The shares underlying the stock units will vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
- [F3]This option was granted on June 20, 2024. The shares underlying this option vest as to 100% of the underlying shares on June 20, 2025.